North America Companion Animal Regenerative Medicine Market Size & Outlook

The companion animal regenerative medicine market in North America is expected to reach a projected revenue of US$ 866.5 million by 2033. A compound annual growth rate of 8.4% is expected of North America companion animal regenerative medicine market from 2026 to 2033.
Revenue, 2025 (US$M)
$464.6
Forecast, 2033 (US$M)
$866.5
CAGR, 2026 - 2033
8.4%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America companion animal regenerative medicine market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

North America companion animal regenerative medicine market highlights

  • The North America companion animal regenerative medicine market generated a revenue of USD 464.6 million in 2025.
  • The market is expected to grow at a CAGR of 8.4% from 2026 to 2033.
  • In terms of segment, stem cells was the largest revenue generating product in 2025.
  • Other Products is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.


North America data book summary

Market revenue in 2025USD 464.6 million
Market revenue in 2033USD 866.5 million
Growth rate8.4% (CAGR from 2026 to 2033)
Largest segmentStem cells
Fastest growing segmentOther Products
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationStem Cells, Platelet-Rich Plasma (PRP), Other Products


Other key industry trends

  • In terms of revenue, North America region accounted for 40.8% of the global companion animal regenerative medicine market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 387.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Companion Animal Regenerative Medicine Market Companies

Name Profile # Employees HQ Website
Ardent View profile 51-100 Atlanta, Georgia, United States, North America https://theardentcompanies.com/
ENSO View profile 11-50 London, England, United Kingdom, Europe https://www.ensotyres.com/
Animal Cell Therapies View profile 1-10 San Diego, California, United States, North America http://actcells.com
Vetherapy View profile 1-10 Coimbrã, Leiria, Portugal, Europe https://www.vetherapy.co/
Medrego View profile 1-10 Riga, Riga, Latvia, Europe https://www.medrego.com/
Dechra Veterinary Products View profile - Overland Park, Kansas, United States, North America http://dechra-us.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

North America companion animal regenerative medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal regenerative medicine market will help companies and investors design strategic landscapes.


Stem cells was the largest segment with a revenue share of 58.89% in 2025. Horizon Databook has segmented the North America companion animal regenerative medicine market based on stem cells, platelet-rich plasma (prp), other products covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to North America companion animal regenerative medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America companion animal regenerative medicine market databook

  • Our clientele includes a mix of companion animal regenerative medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America companion animal regenerative medicine market , including forecasts for subscribers. This continent databook contains high-level insights into North America companion animal regenerative medicine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America companion animal regenerative medicine market size, by country, 2021-2033 (US$M)

North America Companion Animal Regenerative Medicine Market Outlook Share, 2025 & 2033 (US$M)

North America companion animal regenerative medicine market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online